| By Business Wire |
Article Rating: |
|
| November 9, 2012 03:00 AM EST |
Reads: |
268 |
BIT Analytical Instruments GmbH (www.BIT-companies.com)
will be presenting its entire range of services in Hall 03 / F86 at the
“2012 MEDICA World Forum for Medicine” scheduled to take place in
Düsseldorf, Germany, November 14-17, 2012. Details on MEDICA, can be
found on the MEDICA Trade Fair website at http://www.medica-tradefair.com.
BIT Analytical Instruments will be featuring a variety of instruments
including; the recently-unveiled DRG Hybrid Analyzer - a
fully-automated, random-access analyzer for immunoassays and clinical
chemistry, the DiaSys respons910 clinical chemistry analyzer, and the
22AL, a clear covered analyzer example of BIT C2 Diagnostic’s hematology
platform capabilities. All of these instruments have been developed and
manufactured utilizing specialized platform components (software,
electronics and hardware) containing modular systems that can be
customized and assembled to form a complete system. This approach
provides more flexibility, proven reliability and greater efficiency in
instrumentation develop and manufacturing.
Unlike others, BIT’s platforms are not limited to an instrument platform
or customized to only one specific diagnostic process. Instead, they
provide a much broader, horizontal and vertical approach for equipment
of varying size, configuration, process / technology and diagnostics.
This approach translates directly into significant product development
savings.
For over 35 years BIT Companies (http://www.BIT-Companies.com)
have provided services in the field of contract development and
manufacturing as well as after-sales service for customers in the fields
of medical, diagnostics, life science, and biotechnology. As a part of
the financially strong Messer Group, BIT Companies provide their systems
solutions worldwide and in compliance with ISO 13485 and 9001 standards.
As registered contract service providers to the FDA, BIT Companies meet
the stringent regulations with regard to medical and complex medical
technical products while simultaneously adhering to predefined
design-to-cost and time-to-market targets.
BIT Companies include BIT Medtech, Source Scientific, & BIT Analytical
Instruments Ltd. (USA) BIT Analytical Instruments GmbH (Germany); BIT
Technologies (China); BIT Japan (Japan); and C2 Diagnostics (France).
